Want to see IN:INDIAGLYCO full AI Analyst Report?
INDIAGLYCO Stock Chart & Stats
₹1007.65
-₹68.05(-5.10%)
At close: 4:00 PM EST
₹1007.65
-₹68.05(-5.10%)
Day’s Range― - ―
52-Week Range₹229.00 - ₹1,222.85
Previous CloseN/A
Volume301.52K
Average Volume (3M)82.17K
Market Cap
₹23.97B
Enterprise Value₹73.31B
Total Cash (Recent Filing)₹318.66M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)6.7
Beta1.57
Next Earnings
Nov 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.72%
Share Statistics
EPS (TTM)49.39
Shares Outstanding67,026,764
10 Day Avg. Volume155,658
30 Day Avg. Volume82,170
Financial Highlights & Ratios
PEG Ratio0.80
Price to Book (P/B)1.84
Price to Sales (P/S)1.28
P/FCF Ratio-31.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)13.88
Revenue Forecast (FY)₹45.76B
Bulls Say, Bears Say
Bulls Say
Revenue Growth And ProfitabilityContinued revenue expansion alongside positive gross and net margins indicates an established operating base across industrial and specialty chemicals. This supports ongoing reinvestment and suggests the company can retain earnings power even as product mix and input conditions change.
Bio-based Product DifferentiationRenewable feedstock-based chemicals provide a differentiated position beyond standard petrochemical products. Exposure to pharmaceuticals, personal care, coatings, inks and other applications broadens potential demand and can support customer relevance as sustainability requirements become more important.
Improving LeverageThe lower debt-to-equity ratio reduces balance-sheet pressure and improves financial flexibility relative to the prior year. While debt remains material, improving leverage provides a stronger base for managing operating cycles and funding the company’s chemical portfolio over coming quarters.
Bears Say
Persistent Negative Free Cash FlowOngoing negative free cash flow means accounting profitability is not yet translating into surplus cash after investment requirements. This can constrain internally funded growth, reduce capital-allocation flexibility and leave the company more reliant on financing or improved future cash conversion.
Weak Earnings Cash ConversionThe gap between operating cash flow and net income signals that reported earnings are converting into cash inefficiently. Even with a recent operating cash flow rebound, continued weak conversion may limit balance-sheet improvement and make profitability less durable than the income statement suggests.
Gross-margin CompressionThe substantial gross-margin decline shows that profitability remains exposed to cost conditions or changes in product mix. Although net margin improved, sustained margin volatility can weaken earnings predictability and make it harder to preserve returns through different chemical-market cycles.
India Glycols Limited News
INDIAGLYCO FAQ
What was India Glycols Limited’s price range in the past 12 months?
India Glycols Limited lowest stock price was ₹229.00 and its highest was ₹1222.85 in the past 12 months.
What is India Glycols Limited’s market cap?
India Glycols Limited’s market cap is ₹23.97B.
When is India Glycols Limited’s upcoming earnings report date?
India Glycols Limited’s upcoming earnings report date is Nov 05, 2026 which is in 26 days.
How were India Glycols Limited’s earnings last quarter?
India Glycols Limited released its earnings results on Aug 12, 2026. The company reported ₹2.974 earnings per share for the quarter.
Is India Glycols Limited overvalued?
According to Wall Street analysts India Glycols Limited’s price is currently Overvalued.
Does India Glycols Limited pay dividends?
India Glycols Limited pays a Semiannually dividend of ₹7.5 which represents an annual dividend yield of 0.72%. See more information on India Glycols Limited dividends here
What is India Glycols Limited’s EPS estimate?
India Glycols Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does India Glycols Limited have?
India Glycols Limited has 67,026,764 shares outstanding.
What happened to India Glycols Limited’s price movement after its last earnings report?
India Glycols Limited reported an EPS of ₹2.974 in its last earnings report. Following the earnings report the stock price went down -2.126%.
Which hedge fund is a major shareholder of India Glycols Limited?
Currently, no hedge funds are holding shares in IN:INDIAGLYCO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
India Glycols Limited
India Glycols Limited, a green petrochemical company, manufactures and sells industrial chemicals in India. It operates through Bio-based Specialities and Performance Chemicals, Potable Spirits, and Ennature Biopharma segments. The company offers bio mono ethylene, di ethylene, and tri ethylene glycols; ethyl/butyl glycol ethers and acetates, and brake fluids; bio-polymers comprising guar and natural gums; biofuels; specialty chemicals, such as plasticisers, oil fields chemicals, bio-amines, methyl soyate, MDEA and MDEA derivatives, bio-potash granules, and C-Smart specialty products; molasses and grain based extra neutral alcohol; and specialty gases, including industrial and medical oxygen, food grade and industrial carbon dioxide, liquid argon and nitrogen, ethylene oxide, and bio ethylene oxide. It also provides Indian made foreign liquor, such as whiskey under Soulmate Blu and Single Reserve brands; vodka under Amazing brand; and rum under Zumba and Beach House XXX brands, as well as economy spirits under Bunty brand, and branded country liquor. In addition, the company offers natural active pharmaceutical ingredients, nutraceuticals, standardized botanical extracts, and nicotine derivatives. Further, its products find applications in pharma and healthcare; textiles; automotive; personal care; industrial and manufacturing; paints and coatings; oil and gas; food ingredients; packaging; potable spirits; and other various industries. The company also exports its products. The company was formerly known as UP Glycols Limited and changed its name to India Glycols Limited in August 1986. India Glycols Limited was incorporated in 1983 and is headquartered in Noida, India.
Technical Analysis
Deepak Nitrite Limited
―
Gujarat Fluorochemicals Ltd.
―
Godavari Biorefineries Limited
―
Gulshan Polyols Limited
―
Navin Fluorine International Limited
―